In products where members are able to self-refer to providers for care and services, members are advised to use participating providers in order to receive the highest level of benefits.When services can be administered in various settings, the Company reserves the right to reimburse only those services that are furnished in the most appropriate and cost-effective setting that is appropriate to the member’s medical needs and condition. This decision is based on the member’s current medical condition and any required monitoring or additional services that may coincide with the delivery of this service.
For more information on how Claim Payment Policy Bulletins are developed, go to the About This Site section of this Medical Policy Web site.
Policy: 06.02.06p:Genetic Testing for Inherited Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Mutations (Independence Administrators)
Policy: 06.02.10q:Genetic Testing for Inherited Susceptibility to Colon Cancer and Microsatellite Instability Testing (Familial Adenomatous Polyposis and Lynch Syndrome) (Independence Administrators)
Policy: 06.02.27l:Assays of Genetic Expression in Tumor Tissue for Breast Cancer Prognosis (Independence Administrators)
Policy: 06.02.30e:Pharmacogenetic Testing to Determine Drug Sensitivity (Independence Administrators)
Policy: 06.02.32d:Multigene Expression Assays for Predicting Recurrence in Colon Cancer (Independence Administrators)
Policy: 06.02.35x:Genetic Testing (Independence Administrators)